Crucially both TAM abundance and TME expression of M2-associated TAM genes ARG1, MRC1, and IL10 were reduced, concurrent with an increase in CD8+ T cell tumour infiltration, suggesting a preferential targeting of M2-associated immunosuppressive TAM subsets. The gene discussed is CD8A; the disease is neoplasm.